Renuka Pillutla

1.7k total citations
43 papers, 1.1k citations indexed

About

Renuka Pillutla is a scholar working on Molecular Biology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Renuka Pillutla has authored 43 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 22 papers in Immunology and 16 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Renuka Pillutla's work include Biosimilars and Bioanalytical Methods (21 papers), Monoclonal and Polyclonal Antibodies Research (16 papers) and CAR-T cell therapy research (6 papers). Renuka Pillutla is often cited by papers focused on Biosimilars and Bioanalytical Methods (21 papers), Monoclonal and Polyclonal Antibodies Research (16 papers) and CAR-T cell therapy research (6 papers). Renuka Pillutla collaborates with scholars based in United States, Germany and Sweden. Renuka Pillutla's co-authors include Aaron J. Shatkin, Zhenyu Yue, Edio Maldonado, Danny Reinberg, Helen Cho, Jianing Zeng, Binodh DeSilva, Arthur J. Blume, Neil I. Goldstein and Yuanxin Xu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Analytical Chemistry.

In The Last Decade

Renuka Pillutla

43 papers receiving 1.0k citations

Peers

Countries citing papers authored by Renuka Pillutla

Since Specialization

Citations

This map shows the geographic impact of Renuka Pillutla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renuka Pillutla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renuka Pillutla more than expected).

Fields of papers citing papers by Renuka Pillutla

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Renuka Pillutla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renuka Pillutla. The network helps show where Renuka Pillutla may publish in the future.

Co-authorship network of co-authors of Renuka Pillutla

This figure shows the co-authorship network connecting the top 25 collaborators of Renuka Pillutla. A scholar is included among the top collaborators of Renuka Pillutla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Renuka Pillutla. Renuka Pillutla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prevalence of Pre-Existing Neutralizing Antibodies Against Adeno-Associated Virus Serotypes 1, 2, 5, 6, 8, and 9 in Sera of Different Pig Strains 2021 ·Human Gene Therapy ·Yan‐Shan Dai, Uma Kavita, Margit H. Lampen, (unknown), (unknown), Paul Lévesque, Alexander Kozhich, Renuka Pillutla, Yan Zhang, Vibha Jawa, Leonard P. Adam	10
2	Evaluating a Multiscale Mechanistic Model of the Immune System to Predict Human Immunogenicity for a Biotherapeutic in Phase 1 2019 ·The AAPS Journal ·Lora Hamuro, Giridhar Tirucherai, (unknown), Akbar Nayeem, Renuka Pillutla, Binodh DeSilva, Tarek A. Leil, Craig J. Thalhauser	14
3	A Fit-for-Purpose Method for the Detection of Human Antibodies to Surface-Exposed Components of BMS-986263, a Lipid Nanoparticle-Based Drug Product Containing a siRNA Drug Substance 2019 ·The AAPS Journal ·Uma Kavita, (unknown), Qin Ji, Renuka Pillutla	14
4	Application of in-sample calibration curve methodology for regulated bioanalysis: Critical considerations in method development, validation and sample analysis 2019 ·Journal of Pharmaceutical and Biomedical Analysis ·Long Yuan, Huidong Gu, Jianing Zeng, Renuka Pillutla, Qin Ji	9
5	Bead-extraction and heat-dissociation (BEHD): A novel way to overcome drug and matrix interference in immunogenicity testing 2018 ·Journal of Immunological Methods ·Weifeng Xu, (unknown), Jennifer Cummings, Stephen M. Carl, (unknown), Carol Gleason, Robert Dodge, Binodh DeSilva, Gerry Kolaitis, Renuka Pillutla	14
6	A convenient strategy to overcome interference in LC-MS/MS analysis: Application in a microdose absolute bioavailability study 2018 ·Journal of Pharmaceutical and Biomedical Analysis ·Long Yuan, Christine Huang, (unknown), (unknown), (unknown), Alban J. Allentoff, Naiyu Zheng, Ramaswamy A. Iyer, Li Zhu, Renuka Pillutla, Qin Ji	8
7	Development of a Chemiluminescent ELISA Method for the Detection of Total Anti-Adeno Associated Virus Serotype 9 (AAV9) Antibodies 2018 ·Human Gene Therapy Methods ·Uma Kavita, Yan‐Shan Dai, Lisa Salvador, (unknown), Leonard P. Adam, Paul Lévesque, Yan J Zhang, Qin Ji, Renuka Pillutla	18
8	Approaches to Mitigate the Unwanted Immunogenicity of Therapeutic Proteins during Drug Development 2017 ·The AAPS Journal ·Laura I. Salazar‐Fontana, Dharmesh D. Desai, Tarik A. Khan, Renuka Pillutla, Sandra Prior, Radha Ramakrishnan, Jennifer L. Schneider, Alexandra Joseph	32
9	Accelerating Regulated Bioanalysis for Biotherapeutics: Case Examples Using a Microfluidic Ligand Binding Assay Platform 2016 ·The AAPS Journal ·Rong Liu, (unknown), Shannon Chilewski, (unknown), Uma Kavita, (unknown), Carol Gleason, Yan Zhang, Renuka Pillutla, Binodh DeSilva, Lora Hamuro	4
10	Strategies to Determine Assay Format for the Assessment of Neutralizing Antibody Responses to Biotherapeutics 2016 ·The AAPS Journal ·Bonnie Wu, Shan Chung, Xu‐Rong Jiang, Jim McNally, João Pedras-Vasconcelos, Renuka Pillutla, Joleen T. White, Yuanxin Xu, Shalini Gupta	42
11	Development and validation of a liquid chromatography tandem mass spectrometry assay for the quantitation of a protein therapeutic in cynomolgus monkey serum 2015 ·Journal of Chromatography B ·Yue Zhao, Guowen Liu, (unknown), Lora Hamuro, Kevin J. Trouba, Bonnie Wang, Renuka Pillutla, Binodh DeSilva, Mark E. Arnold, Jim X Shen	8
12	Development and characterization of a free therapeutic ligand binding assay with assistance from kinetics modeling 2015 ·Journal of Immunological Methods ·(unknown), (unknown), Anjaneya Chimalakonda, Ni Yan, (unknown), Binodh DeSilva, Renuka Pillutla	3
13	A White Paper—Consensus and Recommendations of a Global Harmonization Team on Assessing the Impact of Immunogenicity on Pharmacokinetic Measurements 2014 ·The AAPS Journal ·Jeffrey Sailstad, Lakshmi Amaravadi, Adrienne Clements‐Egan, Boris Gorovits, Heather Myler, Renuka Pillutla, (unknown), Monique Putman, (unknown), (unknown), (unknown), (unknown)	48
14	Development and characterization of a pre-treatment procedure to eliminate human monoclonal antibody therapeutic drug and matrix interference in cell-based functional neutralizing antibody assays 2014 ·Journal of Immunological Methods ·Weifeng Xu, Hao Jiang, Craig Titsch, (unknown), Renuka Pillutla, Anne‐Françoise Aubry, Binodh DeSilva, Mark E. Arnold, Jianing Zeng, Robert Dodge	19
15	Peptides Identify the Critical Hotspots Involved in the Biological Activation of the Insulin Receptor 2002 ·Journal of Biological Chemistry ·Renuka Pillutla, Ku-chuan Hsiao, James R. Beasley, Jakob Brandt, Søren Østergaard, Per Hansen, Jane C. Spetzler, Gillian M. Danielsen, Asser S. Andersen, R E Brissette, Michael Lennick, Paul W. Fletcher, Arthur J. Blume, Lauge Schäffer, Neil I. Goldstein	74
16	Target validation and drug discovery using genomic and protein–protein interaction technologies 2002 ·Expert Opinion on Therapeutic Targets ·Renuka Pillutla, Paul B. Fisher, Arthur J. Blume, Neil I. Goldstein	16
17	A surrogate-based approach for post-genomic partner identification 2001 ·BMC Biotechnology ·Renuka Pillutla, Ku-chuan Hsiao, R E Brissette, Paul S. Eder, Tony Giordano, Paul W. Fletcher, Michael Lennick, Arthur J. Blume, Neil I. Goldstein	9
18	Human mRNA Capping Enzyme (RNGTT) and Cap Methyltransferase (RNMT) Map to 6q16 and 18p11.22–p11.23, Respectively 1998 ·Genomics ·Renuka Pillutla, Akira Shimamoto, Yasuhiro Furuichi, Aaron J. Shatkin	24
19	Recombinant Human mRNA Cap Methyltransferase Binds Capping Enzyme/RNA Polymerase IIo Complexes 1998 ·Journal of Biological Chemistry ·Renuka Pillutla, Zhenyu Yue, Edio Maldonado, Aaron J. Shatkin	61
20	Deletion of the putative effector region of Era, an essential GTP-binding protein inEscherichia coli, causes a dominant-negative phenotype 1996 ·FEMS Microbiology Letters ·Renuka Pillutla, Joohong Ahnn, Masayori Inouye	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact